NSE · AI Signal & Stock Analysis · Bearish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for MARKSANS is Bearish ↓ (mild move); technical trend raise-2026-11-12; trading at ₹320.00 (+4.39% today); neutral (RSI 55). What changed: the technical trend turned Raise (was down-trend) on 12 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bearish ↓ · Mild move |
|---|---|
| Technical trend | RAISE-2026-11-12 |
| Price | ₹320.00 |
| Change today | +4.39% |
| RSI (14) | 54.90 |
| Relative volume | 0.77 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹14,435 Cr |
| P/E | 25.79 |
| Cap category | Mid Cap |
| 52-week high | -7.9% away |
| 52-week low | +104.0% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - General |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for MARKSANS (Marksans Pharma Limited) is Bearish with a mild move, and its technical trend is raise-2026-11-12. The composite score and full factor breakdown are available to signed-in members.
MARKSANS's RSI is neutral (RSI 55). A reading above 70 is typically overbought and below 30 oversold.
MARKSANS is trading about 8% below its 52-week high and 104% above its 52-week low as of Nov 13 2026, 6:15 AM.
MARKSANS's market capitalisation is ₹14,435 Cr as of Nov 13 2026, 6:15 AM.
MARKSANS is classified under Drug Manufacturers - General in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for MARKSANS — not personalised investment advice. Always do your own research.
GLAXO · PFIZER · RUBICON · SANOFI · SANOFICONR · SENORES
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →